Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Isopropyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL10385582 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL28818229 | 0.88 | — | — | |
| Isopropyl Alcohol SCHEMBL19205891 | 0.88 | — | — | |
| Isopropyl Alcohol SCHEMBL542798 | 0.88 | — | — | |
| Isopropyl Alcohol SCHEMBL8706013 | 0.88 | — | — | |
| Isopropyl Alcohol SCHEMBL14060862 | 0.88 | — | — | |
| Isopropyl Alcohol SCHEMBL5500348 | 0.88 | — | — | |
| Isopropyl Alcohol SCHEMBL10384904 | 0.88 | — | — | |
| Isopropyl Alcohol SCHEMBL7540403 | 0.88 | — | — | |
| Isopropyl Alcohol SCHEMBL28148403 | 0.88 | ALDH1A1 (0.75) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240343738-A1 | Method for preparing pranoprofen and composition comprising pranoprofen and impurity | SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) | 2024-10-17 | — | — | US | claimed |
| US-20240239791-A1 | PROCESSES FOR THE SYNTHESIS OF VALBENAZINE | NEUROCRINE BIOSCIENCES, INC. | 2024-07-18 | — | — | US | claimed |
| WO-2024119985-A1 | METHOD FOR PREPARING SITAGLIPTIN INTERMEDIATE PYRAZINE HYDROCHLORIDE | 台州达辰药业有限公司 | 2024-06-13 | — | — | WO | claimed |
| CN-118108612-A | Preparation method of high-purity L-phenylephrine hydrochloride | 南京海融制药有限公司 | 2024-05-31 | — | — | CN | claimed |
| EP-4361155-A1 | METHOD FOR PREPARING PRANOPROFEN AND COMPOSITION CONTAINING PRANOPROFEN AND IMPURITY | Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) | 2024-05-01 | — | — | EP | claimed |
| CN-117209387-B | Salifying and purifying process of esmolol hydrochloride | 中国海洋大学 | 2024-04-26 | — | — | CN | claimed |
| EP-4330255-A1 | PROCESSES FOR THE SYNTHESIS OF VALBENAZINE | Neurocrine Biosciences, Inc. (US) | 2024-03-06 | — | — | EP | claimed |
| CN-114507184-B | Synthesis method and application of 1-methyl hexahydroazepin-4-one hydrochloride | 好医生药业集团有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-113620826-B | Preparation method of D-p-hydroxyphenylglycine methyl ester hydrochloride suitable for industrial production | 湖北省宏源药业科技股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117480170-A | Method for synthesizing valphenazine | 纽罗克里生物科学有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-110734405-A | Synthesis method of N- (6-aminohexyl) -N '-methyl-2, 2' -biimidazole | 华东数字医学工程研究院 | 2020-01-31 | — | — | CN | claimed |
| CN-110668951-A | Synthesis process of selegiline hydrochloride | 安徽贝克生物制药有限公司 | 2020-01-10 | — | — | CN | claimed |
| CN-110642721-A | Preparation method of selegiline hydrochloride | 安徽贝克生物制药有限公司 | 2020-01-03 | — | — | CN | claimed |
| CN-109705112-A | The preparation method of the novel crystal forms of Lurasidone HCl | 江苏恩华药业股份有限公司 | 2019-05-03 | — | — | CN | claimed |
| CN-109251175-A | The preparation method of pyrimidinones | 广东东阳光药业有限公司 | 2019-01-22 | — | — | CN | claimed |
| CN-105524057-A | Lurasidone hydrochloride new crystal form and preparation method thereof | JIANGSU NHWA PHARMACEUTICAL CO LTD | 2016-04-27 | — | — | CN | claimed |
| US-7880015-B2 | treating N-[[2'-(1-triphenylmethyltetrazol-5-yl)biphenyl-4-yl]methyl]-L-valine methyl ester with oxalic acid to produce N-[[2'-(1-triphenylmethyltetrazol-5-yl)biphenyl-4-yl]methyl]-L-valine methyl ester oxalate, treating intermediate with a base and vlaeryl chloride , deprotecting; Valsartan product | AUROBINDO PHARMA LTD. (IN) | 2011-02-01 | — | — | US | claimed |
| US-20090281326-A1 | Process For the Preparation of Angiotensin II Antagonist | AUROBINDO PHARMA LTD (IN) | 2009-11-12 | — | — | US | claimed |
| EP-2057132-A2 | PROCESS FOR THE PREPARATION OF THE ANGIOTENSIN II ANTAGONIST VALSARTAN | Aurobindo Pharma Limited (IN) | 2009-05-13 | — | — | EP | claimed |
| WO-2008004110-A2 | PROCESS FOR THE PREPARATION OF THE ANGIOTENSIN II ANTAGONIST VALSARTAN | AUROBINDO PHARMA LIMITED (IN) | 2008-01-10 | — | — | WO | claimed |